TP53 and hepatocellular carcinoma: Jiao et al. identified the TP53 R249S mutation in 7.3% of HCC from Hispanic patients living in South Texas but not among 218 HCC non-Hispanic patients and not in 96 subjects with advanced fibrosis or cirrhosis living in the same region, suggesting that AFB-1 exposure may have occurred only in the Hispanic population [59].